SLN
Silence Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$12.20
−3.94%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $124.2K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.14
- Revenue actual
- $137.2K
- Revenue estimate
- $1.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -18.8%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $32
- PT range
- $32 – $32
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.14 | -$0.26 | Miss -87.51% | $137.2K |
| May 7, 2026 | -$0.33 | -$0.32 | Beat 3.03% | $422.0K |
| Mar 5, 2026 | -$0.32 | -$0.25 | Beat 21.88% | — |
| Nov 6, 2025 | -$0.40 | -$0.45 | Miss -12.50% | $159.0K |
| Aug 7, 2025 | -$0.27 | -$0.54 | Miss -100.00% | $224.0K |
| May 8, 2025 | -$0.18 | -$0.60 | Miss -233.33% | $183.7K |
| Nov 14, 2024 | -$0.42 | -$0.75 | Miss -78.57% | $1.5M |
| May 16, 2024 | -$0.23 | -$0.05 | Beat 78.26% | $15.6M |
| Nov 14, 2023 | -$0.56 | -$0.28 | Beat 50.00% | $3.4M |
| Aug 16, 2023 | -$0.59 | -$0.36 | Beat 38.98% | $11.5M |
| May 16, 2023 | -$0.51 | -$0.35 | Beat 31.37% | $14.1M |
| Nov 10, 2022 | -$0.60 | -$0.25 | Beat 58.33% | $3.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026